Florian Brand - Sep 13, 2023 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: Co-Founder & Chief Executive Officer
Signature: /s/ Ryan Barrett, Attorney-in-fact
Stock symbol: ATAI
Transactions as of: Sep 13, 2023
Transactions value $: $57,968
Form type: 4
Date filed: 9/14/2023, 04:30 PM
Previous filing: Mar 30, 2023
Next filing: Nov 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATAI	Common Shares	Purchase	$58K	+40K	+57.14%	$1.45	110K	Sep 13, 2023	Direct	F1
holding	ATAI	Common Shares						2.33K	Sep 13, 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.441 to $1.457. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.441 to $1.457. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Remarks:

Co-Founder & Chief Executive Officer